4.7 Article

Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia

Related references

Note: Only part of the references are listed.
Article Cell Biology

Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies

Jing-dong Zhou et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Article Medical Laboratory Technology

CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics

Ting-juan Zhang et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)

Article Biochemistry & Molecular Biology

Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia

Jing-Dong Zhou et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Medicine, General & Internal

Chronic myeloid leukaemia

Jane F. Apperley

LANCET (2015)

Letter Hematology

Loss of H19 imprinting in adult T-cell leukaemia/lymphoma

Seisho Takeuchi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Review Hematology

The biology of CML blast crisis

B Calabretta et al.

BLOOD (2004)